We are live on ! Find out more
Keene & Associates

Keene & Associates Portfolio holdings

AUM $125M Turnover 12.2%
1-Year Est. Return 13.49%
This Fund
S&P 500
This Quarter Est. Return
-1.8%
1 Year Est. Return
+13.49%
3 Year Est. Return
+20.33%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$125M
AUM Growth
-$7.44M
Cap. Flow
-$3.33M
Cap. Flow %
-2.67%
Top 10 Hldgs %
34.07%
Holding
82
New
4
Increased
37
Reduced
28
Closed
6
Avg Time Held
2.2 years
Top 10 Avg Time Held
0.6 years
Top 20 Avg Time Held
1 year

Top Sells

Rank Stock Value
1
UL icon
Unilever
UL
+$4.16M
2
INTC icon
Intel
INTC
+$2.09M
3
NTR icon
Nutrien
NTR
+$1.09M
4
BWA icon
BorgWarner
BWA
+$1.03M
5
DVN icon
Devon Energy
DVN
+$977K

Sector Composition

Rank Sector Weight
1 Consumer Staples 18.72%
2 Technology 15.13%
3 Healthcare 14.41%
4 Industrials 11.45%
5 Energy 11.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
WMT icon
1
Walmart Inc
WMT
$951B
$4.95M 3.97%
54,790
-3,521
-6% -$306K
2021 Q4
12 quarters
KMI icon
2
Kinder Morgan
KMI
$76.7B
$4.73M 3.8%
172,528
-1,357
-0.8% -$35.4K
2024 Q2
2 quarters
CSCO icon
3
Cisco
CSCO
$420B
$4.41M 3.54%
74,459
+118
+0.2% +$6.74K
2021 Q4
12 quarters
MSFT icon
4
Microsoft
MSFT
$3.89T
$4.28M 3.44%
10,151
+143
+1% +$60.9K
2021 Q4
12 quarters
INGR icon
5
Ingredion
INGR
$6.04B
$4.21M 3.38%
30,578
-146
-0.5% -$20.6K
2021 Q4
12 quarters
FDX icon
6
FedEx
FDX
$70.7B
$4.13M 3.32%
14,698
+416
+3% +$116K
2021 Q4
12 quarters
ORCL icon
7
Oracle
ORCL
$382B
$4.13M 3.32%
24,801
-2,009
-7% -$357K
2021 Q4
12 quarters
GLW icon
8
Corning
GLW
$107B
$4.05M 3.25%
85,201
-4,677
-5% -$222K
2021 Q4
12 quarters
EVRG icon
9
Evergy
EVRG
$19.5B
$3.95M 3.17%
64,239
+316
+0.5% +$19.5K
2024 Q1
3 quarters
DUK icon
10
Duke Energy
DUK
$97.4B
$3.58M 2.88%
33,270
+333
+1% +$37.7K
2021 Q4
12 quarters
BMY icon
11
Bristol-Myers Squibb
BMY
$126B
$3.5M 2.81%
61,881
+326
+0.5% +$18.2K
2021 Q4
12 quarters
TSN icon
12
Tyson Foods
TSN
$19.9B
$3.45M 2.77%
60,123
+1,047
+2% +$63.2K
2021 Q4
12 quarters
VZ icon
13
Verizon
VZ
$186B
$3.41M 2.74%
85,373
+1,380
+2% +$58.2K
2023 Q1
7 quarters
DIS icon
14
Walt Disney
DIS
$194B
$3.37M 2.71%
30,265
+839
+3% +$88.1K
2021 Q4
12 quarters
KMB icon
15
Kimberly-Clark
KMB
$36.6B
$3.32M 2.67%
25,354
+626
+3% +$85.3K
2021 Q4
12 quarters
GD icon
16
General Dynamics
GD
$94.5B
$3.24M 2.6%
12,281
+502
+4% +$145K
2021 Q4
12 quarters
B icon
17
Barrick Mining
B
$62.8B
$3.17M 2.55%
204,775
-6,358
-3% -$116K
2021 Q4
12 quarters
MDT icon
18
Medtronic
MDT
$122B
$3.17M 2.54%
39,649
+708
+2% +$61.3K
2022 Q1
11 quarters
SLB icon
19
SLB Ltd
SLB
$78.7B
$3.12M 2.51%
81,477
+5,956
+8% +$250K
2021 Q4
12 quarters
PEP icon
20
PepsiCo
PEP
$185B
$3.02M 2.43%
19,877
+780
+4% +$128K
2021 Q4
12 quarters
J icon
21
Jacobs Solutions
J
$17B
$2.97M 2.39%
+22,469
New +$3.09M
2024 Q4
0 quarters
JNJ icon
22
Johnson & Johnson
JNJ
$635B
$2.94M 2.36%
20,328
+1,134
+6% +$176K
2021 Q4
12 quarters
MRK icon
23
Merck
MRK
$358B
$2.91M 2.34%
29,240
+2,485
+9% +$256K
2021 Q4
12 quarters
CVX icon
24
Chevron
CVX
$457B
$2.71M 2.18%
18,739
+687
+4% +$105K
2021 Q4
12 quarters
PFE icon
25
Pfizer
PFE
$171B
$2.52M 2.03%
95,073
-16,929
-15% -$459K
2021 Q4
12 quarters

Similar funds

Keene & Associates's Q4 2024 Portfolio in Review

As of Q4 2024, Keene & Associates held 82 positions worth $125M, down 5.6% from $132M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Keene & Associates's Q4 2024 filing shows 4 new, 37 increased, 28 reduced and 6 closed positions. Its largest new stake was Jacobs Solutions: 22,469 shares worth $2.97M. The largest sale was Unilever, an estimated $4.16M.

By sector, the portfolio is most concentrated in Consumer Staples at 19% of assets, down from 19% a quarter earlier, followed by Technology and Healthcare.

  • Keene & Associates's largest Q4 2024 buy was Jacobs Solutions: 22,469 shares worth $2.97M.
  • Keene & Associates added most to PIMCO Ultra Short Government Active ETF in Q4 2024, an estimated $993K increase.
  • Keene & Associates's biggest Q4 2024 reduction was Nutrien, cutting an estimated $1.09M.
  • Keene & Associates fully exited Unilever in Q4 2024, selling an estimated $4.16M.
  • Keene & Associates's ten largest holdings make up 34% of its $125M portfolio in Q4 2024.
  • Keene & Associates opened 4 new positions and closed 6 in Q4 2024.
  • Keene & Associates's portfolio value fell 5.6% quarter-over-quarter to $125M.

Based on Keene & Associates's 13F filing for Q4 2024, filed 3 Feb 2025.